We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPortmeirion Regulatory News (PMP)

Share Price Information for Portmeirion (PMP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 257.50
Bid: 250.00
Ask: 265.00
Change: 2.50 (0.98%)
Spread: 15.00 (6.00%)
Open: 257.00
High: 257.50
Low: 257.00
Prev. Close: 255.00
PMP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Covid-19 and Business Update

30 Mar 2020 11:25

RNS Number : 0460I
Portmeirion Group PLC
30 March 2020
 

30 March 2020

 

Portmeirion Group PLC

('the Group' or 'Portmeirion Group')

 

Covid-19 and Business Update

 

Portmeirion Group PLC, the designer, manufacturer and worldwide distributor of high quality homewares under the Portmeirion, Spode, Royal Worcester, Pimpernel, Wax Lyrical and Nambé brands, announces the following business update.

Further to the announcement of the Group's preliminary results for the year ended 31 December 2019 on 19 March 2020, the Board would like to update on the impact of the Covid-19 virus and the steps we have taken to safeguard the long term health of our business.

Portmeirion Group is a well-diversified business. We sell in over 70 countries, have two UK factories and also work with premium quality sourced factories around the world.

The Board is supportive of the government's efforts to contain Covid-19 and as a Company are fully committed to following all guidance provided and instructions issued by the government and Public Health England to help reduce the spread of Covid-19. As a result and with effect from 26 March 2020, the Group's Stoke-on-Trent ceramic factory has taken a three week temporary break which includes one week of regular planned Easter holiday. The safety of our teams is paramount and we will take this time to work on implementing further safe self-distancing procedures. We have good depth of stock in our warehouses which will continue to supply our customers around the world. Although we are seeing short term order reduction from UK and US retailers due to government restrictions on retail store openings, our online sales grew strongly through March and we have a significant forward export order book. Far Eastern markets, which were first hit by the virus, are now starting to return to normal and we are pleased to be taking significant orders from our export markets. Similarly our supply chains and sourced factories in this part of the world have also resumed work.

Our UK home fragrance company Wax Lyrical has shown great endeavour in the past 10 days, converting two production lines at the Cumbria-based factory to making much needed alcohol-based hand sanitiser and spray. We will be supplying these sanitisers to local communities, care homes, the wider NHS network and pharmacists across the country. We will continue to supply regular Wax Lyrical ranges from current stock in the coming months.

Our management team has responded quickly to the challenges of the Covid-19 outbreak. Cash retention initiatives have already been implemented including delaying dividend payments, stripping back capital expenditure and cutting non-essential spend. Recent government announcements regarding 'job retention schemes' are also very beneficial to reducing our short term operational cost base. Taken altogether, the steps we have taken allow us to retain significant further cash within our business, in addition to our already committed bank facilities and headroom.

We therefore believe that, despite the uncertainty that the virus presents, the business is well positioned in the short and long term.

Once there is greater clarity on the outlook and advice from governments in the UK and US regarding retail store closures and travel restrictions we will provide further updates to the market as appropriate.

We are confident in the strength and global reach of our brands and remain committed to our long term strategy.

 

Notes: This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

ENQUIRIES:

 

Portmeirion Group PLC:

Mike Raybould

+44 (0) 1782 744 721

mraybould@portmeiriongroup.com

Chief Executive Officer

David Sproston

 

+44 (0) 1782 744 721

 

dsproston@portmeiriongroup.com

Group Finance Director

 

Hudson Sandler:

Dan de Belder

+44 (0) 207 796 4133

ddebelder@hudsonsandler.com

Nick Moore

nmoore@hudsonsandler.com

 

Panmure Gordon

(Nominated Adviser and Broker):

 

+44 (0) 207 886 2500

Freddy Crossley / Joanna Langley

Corporate Finance

James Stearns

Corporate Broking

 

Cantor Fitzgerald Europe

(Joint Broker):

 

+44 (0) 207 894 7000

Phil Davies / Rick Thompson

Corporate Finance

Caspar Shand Kydd

Sales

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDBGGDXBDXDGGG
Date   Source Headline
17th Apr 20247:00 amRNSAnnual Report & Accounts and Notice of AGM
4th Apr 20242:41 pmRNSHolding(s) in Company
27th Mar 20247:00 amRNSNotice of Investor Presentation
17th Jan 20247:00 amRNSFY23 Trading Update
28th Nov 20235:10 pmRNSHolding(s) in Company
22nd Nov 202311:03 amRNSHolding(s) in Company
19th Oct 20237:00 amRNSUS market product and marketing initiatives
28th Sep 202312:39 pmRNSHolding(s) in Company
18th Sep 202312:02 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSInterim Results
11th Sep 20237:00 amRNSNotice of Investor Presentation
8th Sep 20237:00 amRNSNotice of Interim Results
20th Jul 20237:00 amRNSTrading Update
12th Jun 20233:37 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSBoard Appointment
23rd May 20231:58 pmRNSAGM Resolutions
23rd May 20237:00 amRNSAGM Trading Statement
16th May 20237:00 amRNSNew Sustainability Strategy and Roadmap
3rd May 202311:39 amRNSGrant of Options
14th Apr 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
23rd Mar 20237:00 amRNSPreliminary Results
6th Mar 20237:00 amRNSNotice of Investor Presentation
27th Feb 20234:43 pmRNSHolding(s) in Company
24th Feb 20237:00 amRNSAppointment of Nomad and Joint Broker
23rd Feb 20237:00 amRNSAIM Rule 17 Schedule 2(g) Update
12th Jan 20237:00 amRNSTrading Update
3rd Nov 20227:00 amRNSAnnouncement of new design collaboration
13th Oct 20223:50 pmRNSHolding(s) in Company
26th Sep 20227:00 amRNSExercise of Options and PDMR Shareholdings
15th Sep 20227:00 amRNSInterim Results
8th Sep 20227:00 amRNSLaunch of new UK ecommerce sites
7th Sep 20227:00 amRNSInvestor Results Presentation
2nd Sep 20223:08 pmRNSNotice of Interim Results
15th Aug 20227:00 amRNSAcquisition of AromaWorks London
14th Jul 20227:00 amRNSTrading Update
7th Jul 20227:00 amRNSDirectorate Changes
1st Jul 202210:59 amRNSHolding(s) in Company
29th Jun 20223:18 pmRNSHolding(s) in Company
15th Jun 20223:08 pmRNSDirectors’ Dealings
19th May 20222:38 pmRNSAGM Resolutions
19th May 20227:00 amRNSAGM Trading Statement
12th May 202212:54 pmRNSHolding(s) in Company
26th Apr 20221:49 pmRNSGrant of Options
17th Mar 20227:00 amRNSPreliminary Results
7th Mar 20227:00 amRNSInvestor Results Presentation
24th Feb 20224:20 pmRNSAIM Rule 17 Schedule 2(g) Update
2nd Feb 202211:00 amRNSCapital Markets Day
12th Jan 20227:00 amRNSTrading Update
11th Nov 20217:15 amRNSTrading Update
14th Sep 20217:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.